News & Advocacy
posted: April 21, 2020
Hydroxychloroquine is a FDA-approved drug prescribed for the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and many more in addition to serving as an...
Read More
posted: April 16, 2020
Due to the ongoing uncertainty regarding the COVID-19 pandemic, OAR is postponing the 2020 Advocacy Day which was to be held on May 21, to a future date yet to be determined. We will be monitoring...
Read More
posted: March 23, 2020
Telemedicine is at the top of Ohio decisionmakers’ list right now in response to the pandemic.The State Medical Board of Ohio (SMBO, Medical Board) met on Wednesday, March 18, 2020 and voted...
Read More
posted: March 23, 2020
ongress and the Administration have been working around the clock as policymakers roll out a three phase economic relief package to address the pandemic and those hit hardest by COVID-19.Phase 1 of...
Read More
posted: March 23, 2020
Ohio House Bill 418 was Introduced in the Ohio Legislature by Joint Sponsors Representatives Carruthers (R-51) and Clites (D-75) in November. The bill protects patients by prohibiting medication...
Read More
posted: March 23, 2020
Regulations on Telehealth have literally lessened overnight, and the medical community is now faced with implementing the use of telemedicine in their practices without delay, and many of them for...
Read More
posted: March 23, 2020
OAR is looking to hear from providers and patients who have been impacted by non-medical switching practices to share their experiences. Your testimony will bring greater awareness to the negative...
Read More
posted: March 23, 2020
OAR is carefully monitoring the COVID-19 pandemic and will update the OAR website registration page to reflect any changes. Please register and save the date on your calendar to attend this...
Read More
posted: March 20, 2020
In order to reduce drug costs and improve patient access to treatment, OAR believes increased transparency and appropriate oversight of how PBMs operate in Ohio should be of high priority for...
Read More
posted: March 20, 2020
The ODM began implementation of their Unified Preferred Drug List (UPDL) on January 1, 2020. According to the ODM, the UPDL was developed to reduce confusion, hassles, and potential delays for...
Read More
posted: March 20, 2020
Providers of rheumatology across the country are now able to access information on enacted laws and pending legislation that affects their practices through CSRO’s new map tool. View...
Read More
posted: December 2, 2019
OAR is pleased to announce that House Bill 418 was Introduced in the Ohio Legislature by Joint Sponsors Representatives Carruthers (R) and Clites (D) in November. OAR looks forward to leading the...
Read More
posted: December 2, 2019
The current rebate system allows for pharmacy benefit managers (PBMs) to reap profits on the backs of health plans and patients. In order to reduce drug costs and improve patient access to...
Read More
posted: December 2, 2019
The 7th Annual OAR Joint Advocacy Day with the Arthritis Foundation will be held in April 2020. Advocates will gather in downtown Columbus for breakfast and a legislative briefing prior to...
Read More
posted: December 2, 2019
Coverage changes have occurred under Paramount plans due to the way Paramount is now managing their pharmacy benefits. Magellan Rx Management, a pharmacy benefit manager (PBM), is under contract...
Read More
posted: December 2, 2019
Following a report released in September, Medicaid Director Maureen Corcoran proclaimed the state was now getting a better deal on prescription drugs due to the success of the “pass-through...
Read More
posted: December 2, 2019
Beginning January 1, 2020, the Ohio Department of Medicaid (ODM) and Medicaid Managed Care Plans (MCPs) will begin using a Unified Preferred Drug List (UPDL) which will establish a single PBM to...
Read More
posted: October 7, 2019
More information can be found on Ohio.com.
Read the Full Article
posted: September 23, 2019
Find out more on the Columbus Dispatch.
Read More
posted: September 4, 2019
OAR members and attendees at the annual conference on August 24, 2019 who attended Dr. Ott’s Advocacy Update session heard a summary of all the activities OAR has conducted over the course of...
Read More